Orexo AB (publ)

OTCPK:ORXO.F Stock Report

Market Cap: US$29.7m

Orexo Management

Management criteria checks 3/4

Orexo's CEO is Nikolaj Sorensen, appointed in Feb 2013, has a tenure of 11.75 years. total yearly compensation is SEK6.12M, comprised of 59.5% salary and 40.5% bonuses, including company stock and options. directly owns 0.52% of the company’s shares, worth $154.21K. The average tenure of the management team and the board of directors is 5.8 years and 4.6 years respectively.

Key information

Nikolaj Sorensen

Chief executive officer

SEK 6.1m

Total compensation

CEO salary percentage59.5%
CEO tenure11.8yrs
CEO ownership0.5%
Management average tenure5.8yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Nikolaj Sorensen's remuneration changed compared to Orexo's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 105m

Jun 30 2024n/an/a

-SEK 97m

Mar 31 2024n/an/a

-SEK 73m

Dec 31 2023SEK 6mSEK 4m

-SEK 128m

Sep 30 2023n/an/a

-SEK 201m

Jun 30 2023n/an/a

-SEK 195m

Mar 31 2023n/an/a

-SEK 218m

Dec 31 2022SEK 6mSEK 4m

-SEK 178m

Sep 30 2022n/an/a

-SEK 152m

Jun 30 2022n/an/a

-SEK 177m

Mar 31 2022n/an/a

-SEK 216m

Dec 31 2021SEK 10mSEK 4m

-SEK 223m

Sep 30 2021n/an/a

-SEK 207m

Jun 30 2021n/an/a

-SEK 240m

Mar 31 2021n/an/a

-SEK 198m

Dec 31 2020SEK 9mSEK 3m

-SEK 84m

Sep 30 2020n/an/a

SEK 4m

Jun 30 2020n/an/a

SEK 201m

Mar 31 2020n/an/a

SEK 288m

Dec 31 2019SEK 6mSEK 3m

SEK 219m

Sep 30 2019n/an/a

SEK 232m

Jun 30 2019n/an/a

SEK 182m

Mar 31 2019n/an/a

SEK 178m

Dec 31 2018SEK 5mSEK 3m

SEK 138m

Sep 30 2018n/an/a

SEK 113m

Jun 30 2018n/an/a

SEK 79m

Mar 31 2018n/an/a

SEK 32m

Dec 31 2017SEK 6mSEK 4m

SEK 23m

Compensation vs Market: Nikolaj's total compensation ($USD559.84K) is about average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Nikolaj's compensation has increased whilst the company is unprofitable.

CEO

Nikolaj Sorensen (52 yo)

11.8yrs

Tenure

SEK 6,118,000

Compensation

Mr. Nikolaj Sørensen serves as Independent Director at Bioservo Technologies AB (publ) since May 6, 2019. He is Director at Gesynta Pharma AB. He has been the Chief Executive Officer of Orexo AB since Febr...

Leadership Team

NamePositionTenureCompensationOwnership
Nikolaj Sorensen
President & CEO11.8yrsSEK 6.12m0.52%
$ 154.2k
Fredrik Jarrsten
Executive VP & CFO2.3yrsno data0.076%
$ 22.5k
Cecilia Coupland
Senior VP & Head of Operations5.8yrsno data0.042%
$ 12.4k
Lena Wange
Investor Relations & Communications Directorno datano datano data
Robert Ronn
Senior VP and Head of R&D5.8yrsno data0.059%
$ 17.4k
Edward Kim
Chief Medical Officer2.1yrsno datano data
Robert Deluca
President of Orexo US Inc11.8yrsno data0.051%
$ 15.1k
Jesper Lind
Advisorno datano datano data

5.8yrs

Average Tenure

54.5yo

Average Age

Experienced Management: ORXO.F's management team is seasoned and experienced (5.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
George Wilkinson
Independent Director5.6yrsSEK 400.00k0.056%
$ 16.5k
James Noble
Independent Chairman of the Board4.6yrsSEK 1.50m0.19%
$ 55.5k
Staffan Lindstrand
Independent Director22.8yrsSEK 450.00k0.099%
$ 29.4k
Christine Rankin
Independent Director2.6yrsSEK 550.00k0.023%
$ 6.8k
Robin Evers
Independent Director1.1yrsSEK 50.00kno data

4.6yrs

Average Tenure

62yo

Average Age

Experienced Board: ORXO.F's board of directors are considered experienced (4.6 years average tenure).